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Abstract: Plants of the Lauraceae family are widely used in traditional medicine and are 
sources of various classes of secondary metabolites. Two genera of this family, Beilschmiedia 
and Endiandra, have been the subject of numerous investigations over the past decades 
because of their application in traditional medicine. They are the only source of bioactive 
endiandric acid derivatives. Noteworthy is that their biosynthesis contains two consecutive 
non-enzymatic electrocyclic reactions. Several interesting biological activities for this 
specific class of secondary metabolites and other constituents of the two genera have been 
reported, including antimicrobial, enzymes inhibitory and cytotoxic properties. This review 
compiles information on the structures of the compounds described between January 1960 
and March 2015, their biological activities and information on endiandric acid biosynthesis, 
with 104 references being cited. 
Keywords: Lauraceae; Beilschmiedia; Endiandra; chemical constituents; endiandric acid; 
alkaloids; biological activities 
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1. Introduction 
The family Lauraceae is one of the most important groups of Angiosperms and consists of 55 genera 
and over 2000 species [1–5]. Beilschmiedia is one of the largest pantropical genera in the Lauraceae, 
comprising about 250 species [6–8]. Most of its species grow in tropical climates, but few of them are 
native to temperate regions, and they are widespread in tropical Asia, Africa, Madagascar, Australia, 
New Zealand, North America, Central America, the Caribbean, and South America [6–8]. Regarding 
Endiandra, there are about 125 species found throughout the tropical regions, including 10 species in 
Malaysia [3,9–11]. Very little information is available on the medicinal use of plants of the Endiandra 
genus, but some Beilschmiedia species have been used in the indigenous system of medicine for the 
treatment of various disorders such as uterine tumours, rubella, female genital infections, rheumatism, 
colon and digestive disorders, malaria, headache, as well as bacterial or fungal infections [12–14].  
The fruit of some species are used as appetite stimulants and also as spices [15–18]. 
Beilschmiedia and Endiandra species have been known for a long time as rich sources of biologically 
active secondary metabolites. They have been the subject of very intensive chemical investigations by 
various research groups starting from the middle of the 1960s, with a large number of compounds isolated 
from different species. However, phytochemical investigations have been mostly conducted on 31 
species of Beilschmiedia (Beilschmiedia alloiophylla, B. anacardioides, B. bernesii, B. brevipes,  
B. chancho chancho, B. collina, B. costaricensis, B. cryptocaryoides, B. elliptica, B. erythrophloia, B. fulva, 
B. tsangii, B. ferruginea, B. kunstleri, B. madang, B. manii, B. miersii, B. obscura, B. obtusifolia, B. oligandra, 
B. oreophila Schlechter, B. pendula, B. podagrica, Beilschmiedia spp (from Gabon), B. talaranensis,  
B. tarairie, B. tawa, B. tooram, B. tovarensis, B. volckii, and B. zenkeri) [12,13,15–31] and 11 species of 
Endiandra (Endiandra anthropophagorum, E. bassaphila, E. baillonii, E. introsa, E. jonesii, E. kingiana, 
E. leptodendron, E. monothyra, E. palmerstonii, E. xanthocarpa, and E. wolfii) [32–43]. These investigations 
led to the isolation and characterization of various classes of secondary metabolites, of which endiandric 
acid derivatives, epoxyfuranoid lignans, kingianins (compounds with unique pentacyclic skeleton), and 
alkaloids exhibited antibacterial, anti-inflammatory, and anticancer activities and inhibited different 
enzymes [17–54]. Endiandric acid derivatives, polycyclic fatty acids that possess among others also  
anti-asthmatic activity have been isolated only from plants of the genera Beilschmiedia and Endiandra. 
The biosynthesis of this class of secondary metabolites contains two consecutive non-enzymatic 
electrocyclic reactions [35,36,55]. 
2. Chemical Constituents 
2.1. Endiandric Acid Derivatives from Beilschmiedia and Endiandra 
Plants of the genera Beilschmiedia and Endiandra have been known for a long time as rich source of 
endiandric acid derivatives. They are still the only sources of this class of secondary metabolites. 
Endiandric acid derivatives have been found in 11 species of Beilschmiedia (Beilschmiedia anacardioides, 
B. alloiophylla, B. cryptocaryoides, B. erythrophloia, B. ferruginea, B. fulva, B. manii, Gaboneses 
Beilschmiedia spp, B. oligandra, B. obtusifolia, B. tooram, and B. tsangii) [17,19,20,22–24,44,48,52–54] 
and in 4 species of Endiandra (Endiandra baillonii, E. introsa, E. jonesii, and E. kingiana) [34,40].  
All these compounds have some structural properties in common, such as the cyclic nature, the presence 
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of double bonds and terminal carboxylic acid groups. They can be grouped according to the carbon 
skeleton layout into three groups. The first group is that of compounds characterized by a 13 carbon 
atom fused tetracyclic ring system containing 8,9 and 4,5 or 5,6 (1); the second group is that of 
compounds with tetracylic ring system formed with 11 carbon atoms with 10,11 (2) and the last group 
contains compounds that possess bi-, tri- or tetracyclic ring systems other than skeleton 1 and 2.  
The side chain attached to C-11 in 1 or C-4 in 2 contains in some case double bonds, phenyl residues, or 
a methylenedioxyphenyl moiety. The substituents at C-6 in 1 or C-8 in 2 are usually a carboxylic acid, 
a phenyl ring or a methylenedioxyphenyl fragment. 
 
2.1.1. Endiandric Acid Derivatives with an 13 Carbon Atoms Fused Tetracyclic Ring System (Table 1) 
The first members of this class of compound, endiandric acid A and B (3–4) were isolated from the 
leaves of Endiandra introrsa [35–39]. Endiandric acid A (3) was also obtained from the leaves of other 
species such as B. obtusifolia and B. oligandra [40]. Endiandric acid B (4) was also isolated from  
E. jonesii, E. baillonii and B. tooram [40]. In addition to endiandric acid A (1), a new derivative,  
3'',4''-methylenedioxy endiandric acid A (5) was obtained from B. oligandra after methylation of the 
extract and isolation of the non-natural methylated derivative 6 [40]. Endiandric acid H (7), a derivative 
with a hydroxyl group at C-4, was isolated from the stem of Beilschmiedia fulva [53,54]. Other 
endiandric acid analogues of this group with C8 alkyl side chain attached to the carbon C-11, named 
beilschmiedic acid A–E (8–12), in addition with beilschmiedic acid F (13) were isolated from the stem 
bark of B. anacardioides [17,19,20]. 
From the leaves of an unidentified Beilschmiedia species from Gabon, eight new beilschmiedic acid 
derivatives, named beilschmiedic acid H-O (14–21) were isolated using high-throughput natural 
products chemistry methods [48]. These compounds possess a phenylalkyl side chain at C-11, containing 
generally two trans-configured double bonds. A cis double bond, not reported previously in the side 
chain of endiandric acid derivatives was observed in beilschmiedic acid M (18) [48]. Beilschmiedic acid 
N (20) contains an unusual endoperoxide phenyl moiety that might have been formed during the process 
of isolation [48]. 
The phytochemical investigation of the root of B. erythrophloia resulted in the isolation of endiandric 
acid derivatives erythrophloins A–F (22–27) [41]. 
Endiandric acids with 13 carbon atoms fused tetracyclic ring system tsangibeilin A (28), tsangibeilin 
B (29), tsangibeilin C (30), tsangibeilin D (31) and the amide endiandramide A (32) have also been 
isolated from the roots of B. tsangii [22,23,52]. 
Four beilschmiedic acid derivatives with different oxidation states at C-4, cryptobeilic acids A–D (33–36), 
together with the known tsangibeilin B (29) were isolated from the bark of B. cryptocaryoides collected 
in Madagascar [52]. Other endiandric acid analogues, named ferrugineic acids A–J (37–46) were isolated 
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from the leaves and flowers extracts of B. ferruginea with the help of 1H and 13C HSQC NMR screening 
of ethyl acetate extracts and fractions [24]. 
The investigation of the methanolic extract of the bark of Endiandra kingiana led to the isolation of 
further endiandric acid analogs kingianic acids F (47), G (48) and endiandric acid (49) [34]. 
Table 1. Substitution pattern of endiandric acid derivatives with skeleton 1. 
 
Compounds R1 R2 R3 R4 Unsaturation Sources Ref. 
Endiandric acid A (3) Phenyl H CH2COOH H 4,5, 8,9 
Leaves, B. obstusifolia, 
B. tooram, E. introrsa 
[35–40] 
Endiandric acid B (4) Phenyl H CH2CH=CHCOOH H 4,5, 8,9 
Leaves, B. jonesii,  
E. introrsa, B. tooram 
[40] 
3'',4''-methylenedioxy  
Endiandric acid A (5) 
 H CH2COOH H 
4,5, 8,9 
Leaves, B. oligandra, 
stem bark, B. manii, 
[40,44] 
3'',4''-methylenedioxy 
Endiandric acid  
A methyl ester (6) 
 H CH2COOMe H 
4,5, 8,9 
Synthesis, methylation 
of B. oligandra extract 
[40] 
Endiandric acid H (7)  -OH CH2COOH H 
5,6, 8,9 Stem, B. fulva [53,54] 
Beilschmiedic acid A (8) COOH -OH H 5,6, 8,9 Leave, Beilschmiedia spp [17,48] 
Beilschmiedic acid B (9) COOH -OH  OH 5,6, 8,9 
Leaves, Beilschmiedia 
spp; Bark,  
B. anacardioides 
[17] 
Beilschmiedic acid C (10) COOH -OH  H 5,6, 8,9 
Leaves, Beilschmiedia 
spp; Bark, B. 
anacardioides 
[17,48] 
Beilschmiedic acid D (11) COOH H H 5,6, 8,9 Bark, B. anacardioides [20] 
Beilschmiedic acid E (12) COOH H H 4,5, 8,9 Bark, B. anacardioides [20] 
Beilschmiedic acid F (13)  =O CH2COOH H 
5,6, 8,9 Bark, B. anacardioides [19] 
Beilschmiedic acid H (14) COOH -OH H 5,6, 8,9 Leave , Beilschmiedia spp [48] 
Beilschmiedic acid I (15) COOH -OH H 5,6, 8,9 Leaves, Beilschmiedia spp [48] 
Beilschmiedic acid J (16) COOH H H 5,6, 8,9 Leaves, Beilschmiedia spp [48] 
Beilschmiedic acid K (17) COOH -OH H 5,6, 8,9 Leaves, Beilschmiedia spp [48] 
Beilschmiedic acid M (18) COOH -OH H 5,6, 8,9 Leaves, Beilschmiedia spp [48] 
Beilschmiedic acid L (19) COOH -OH H 5,6, 8,9 Leaves, Beilschmiedia spp [48] 
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Table 1. Cont. 
Compounds R1 R2 R3 R4 Unsaturation Sources Ref. 
Beilschmiedic acid N (20) COOH -OH H 5,6, 8,9 Leaves, Beilschmiedia spp [48] 
Beilschmiedic acid O (21) COOH -OH H 5,6, 8,9 Leaves, Beilschmiedia spp [48] 
Erythrophloin A (22) COOMe H H 4,5, 8,9 Roots, B. erythrophloia [41] 
Erythrophloin B (23) COOMe H H 4,5, 8,9 Roots, B. erythrophloia [41] 
Erythrophloin C (24) COOMe H H 4,5, 8,9 Roots, B. erythrophloia [41] 
Erythrophloin D (25) COOMe H H 4,5, 8,9 Roots, B. erythrophloia [41] 
Erythrophloin E (26) COOH H H 4,5, 8,9 Roots, B. erythrophloia [41] 
Erythrophloin F (27) COOH H H 4,5, 8,9 Roots, B. erythrophloia [41] 
Tsangibeilin A (28) COOH H H 4,5, 8,9 Roots, B. tsangii [23] 
Tsangibeilin B (29) COOH H  H 
4,5, 8,9 
Roots, B. tsangii;  
Bark, B. cryptocaryoides 
[34,41,52] 
Tsangibeilin C (30) COOH =O H 5,6, 8,9 Roots, B. tsangii [22] 
Tsangibeilin D (31) COOH =O OH 5,6, 8,9 Roots, B. tsangii [22] 
Endiandramide A (32) CONHCH2-ipr H H 45, 8,9 Roots, B. tsangii [23] 
Cryptobeilic acid A (33) COOH -OH H 5,6, 8,9 Bark, B. cryptocaryoides [52] 
Cryptobeilic acid B (34) COOH -OH H 5,6, 8,9 Bark, B. cryptocaryoides [52] 
Cryptobeilic acid C (35) COOH =O H 5,6, 8,9 Bark, B. cryptocaryoides [52] 
Cryptobeilic acid D (36) COOH H H 4,5, 8,9 Bark, B. cryptocaryoides [52] 
Ferrugineic acid A (37) COOH H  H 
4,5, 8,9 
Leaves, flowers;  
B. ferruginea 
[24] 
Ferrugineic acid B (38) COOH H 
 
H 4,5, 8,9 
Leaves, flowers,  
B. ferruginea 
[24] 
Ferrugineic acid C (39) COOH H 
 
H 4,5, 8,9 
Leaves, flowers,  
B. ferruginea 
[24] 
Ferrugineic acid D (40) COOH H 
 
H 4,5, 8,9 
Leaves, flowers,  
B. ferruginea 
[24] 
Ferrugineic acid E (41) COOH H  H 
4,5, 8,9 
Leaves, flowers,  
B. ferruginea 
[24] 
Ferrugineic acid F (42) COOH -OH  H 
5,6, 8,9 
Leaves, flowers,  
B. ferruginea 
[24] 
Ferrugineic acid G (43) COOH -OH H 5,6, 8,9 B. ferruginea [24] 
Ferrugineic acid H (44) COOH =O  H 
5,6, 8,9 
Leaves, flowers,  
B. ferruginea 
[24] 
Ferrugineic acid I (45) COOH -OH H 5,6, 8,9 B. ferruginea [24] 
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Table 1. Cont. 
Compounds R1 R2 R3 R4 Unsaturation Sources Ref. 
Ferrugineic acid J (46) COOH -OH 
 
H 5,6, 8,9 
Leaves, flowers,  
B. ferruginea 
[24] 
Kingianic acid F (47) COOH H H 4,5, 8,9 Bark, E. kingiana [34] 
Kingianic acid G (48) COOH -OH H 5,6, 8,9 Bark, E. kingiana [34] 
Endiandric acid (49) COOH H H 5,6, 8,9 Bark, E. kingiana [34] 
2.1.2. Endiandric Acid Derivatives with an 11 Carbon Atoms Fused Tetracylic Ring System (Table 2) 
The first compound with this basic skeleton 2, endiandric acid C (50), was isolated from the leaves 
of Endiandra introrsa [38–40]. This compound was also obtained from the leaves of other species such 
as B. tooram, E. jonesii and E. baillonii [40]. From the root of B. erythrophloia, endiandric acid I (51) 
and endiandric acid J (52) were isolated [49]. Further investigation of this species afforded a 
methylketone derivative named beicyclone A (53) [41]. The investigation of the roots of B. tsangii, 
afforded the new derivatives endiandric acids K (54), L (55), M (56), and endrindramide B (57) having 
an amide group at C-8 [23]. 
From the leaves of B. ferruginea, one endiandric acid analogue, ferrugineic acid K (58) also with 
skeleton 2, was isolated. Other derivatives, kingianic acids A–E (59–63) with phenylalkyl side chains 
were isolated recently from the stem bark of E. kingiana [34]. 
Table 2. Structures of endiandric acid derivatives with skeleton 2.  
 
Compounds R1 R2 Sources Ref. 
Endiandric acid C (50) COOH B. tooram, B. oligandra, E. jonessi, E. introsa [38,40] 
Endiandric acid I (51) COOH Root, B. erythrophloia [49] 
Endiandric acid J (52) COOH Root, B. erythrophloia [49] 
Beicyclone A (53) COCH3 Root, B. erythrophloia [41] 
Endiandric acid K (54) COOH Roots, B. tsangii [23] 
Endiandric acid L (55) CH=CHCOOH Roots of B. tsangii [23] 
Endiandric acid M (56) CH=CH-COOH Roots of B. tsangii, stem bark E. kingiana [23,34] 
Endiandramide B (57) CONHCH2iPr B. tsangii [23] 
Ferrugineic acid K (58) CH=CH-COOH B. ferruginea [24] 
Kingianic acid A (59) COOH Stem bark, E. kingiana [34] 
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Table 2. Cont. 
Compounds R1 R2 Sources Ref. 
Kingianic acid B (60) COOH Stem bark, E. kingiana [34] 
Kingianic acid C (61) COOH Stem bark, E. kingiana [34] 
Kingianic acid D (62) COOH Stem bark, E. kingiana [34] 
Kingianic acid E (63)  -CH2COOH Stem bark, E. kingiana [34] 
2.1.3. Other Endiandric Acid Derivatives 
This group contains compounds that possess bi-, tri- or tetracyclic fused ring systems other  
than skeleton 1 and 2. In this group are beilschmiedic acid G (64) having an aromatic ring and 
beilschmiedin (65) with a seven-membered cyclic ether group isolated from B. anarcardiodes [19,20]; 
tricyclotsangibeilin, an endiandric acid derivative with cyclododecane ring system (66) isolated from the 
roots of B. tsangii [22] and the bicyclic endiandric acids D (67), E (68), F (69) and G (70) isolated from 
E. introrsa [35–40]. 
 
A total of 69 endiandric acid derivatives were isolated from 11 Beilschmiedia and four Endiandra 
plant species with the majority of these secondary metabolites having skeleton 1. 
2.1.4. Biosynthesis of Endiandric Derivatives 
Endiandric acids are polycyclic fatty acid derivatives with particular scaffolds isolated until date only 
in Beilschmiedia and Endiandra species of the Lauraceae family. They are products of electrocyclic ring 
closures of naturally occurring polyketides, resulting from both the shikimate and acetate pathways 
(Scheme 1). 
 
Scheme 1. General biosynthesis scheme of polyketides. 
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Their biosyntheses from the polyketide contain two consecutive non-enzymatic electrocyclic reactions, 
followed by an intramolecular Diels-Alder reaction [35,36,55]. As a result of the whole reaction 
sequence, an open-chain compound is converted into a tetracyclic compound. The starting product 
contains a conjugated tetraene system, as well as a conjugated diene system. Thus, it already displays 
the  electron systems required for the three pericyclic reactions; they are the two electrocyclizations 
and the Diels-Alder reaction [35,36,55] (Scheme 2). 
 
Scheme 2. General biosynthesis scheme of endiandric acid skeleton from polyketides.  
a: Conrotatory 8 electron cyclization; b: Disrotatory 6 electron cyclization;  
c: Diels-Alder cyclization. 
Biogenesis of compounds of the kingianin family of natural products isolated from E. kingiana also 
involve a key Diels-Alder cycloaddition via a tandem 8/6 electrocyclisation. In fact, an arylpolyene 
undergoes a conrotatory 8 e electrocyclization followed by a disrotatory 6 e electrocyclization of the formed 
cyclooctatriene. Radical cation formal Diels-Alder reaction between two bicyclo[4.2.0]octa-2,4-diene 
monomers led to unique and complex pentacyclic derivatives as shown in the Scheme 3 [42]. 
 
Scheme 3. General biosynthesis scheme of kingianin derivatives. a: Conrotatory 8 electron 
cyclization; b: Disrotatory 6 electron cyclization; c: Diels-Alder cyclization. 
2.1.5. Spectroscopic Characterization 
The structures of endiandric acid derivatives have mainly been proposed on the basis of modern 
spectroscopic methods and sometimes X-ray diffraction analysis. The majority of these compounds 
possess a C11 or C13 tetracyclic ring system along with a number of double bonds and substituents that 
display characteristic spectroscopic properties. 
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2.1.5.1. Mass Spectra 
The mass spectrum of endiandric acid derivatives with C13 fused tetracyclic ring system having C4=C5 
double bond generally exhibits an unusual fragmentation pattern where a strong M-78 ion is often observed, 
due to the loss of a benzene moiety (Scheme 4) [35,36]. Most of the EI spectra exhibited base peaks at m/z 
172 or m/z 129 like those of beilschmiedic acid A and C (Scheme 5). Other fragments corresponding to 
cleavage of the side chain and the dehydration have also been observed (Scheme 5) [17,19,20]. 
 
Scheme 4. Fragmentation encountered in some endiandric acid [21]. 
 
Scheme 5. Fragmentation mechanism of beilschmiedic acid A and C, EI, 70 eV [17]. 
2.1.5.2. NMR Spectra 
The 1H-NMR spectra of endiandric acid derivatives are complex and structure elucidation has to rely 
on a combination of 1D- and 2D-NMR techniques. 1H-NMR spectra of derivatives with skeleton 1 
having C4=C5 double bond showed, among other peaks, a broad singlet of the methine proton H-7 around 
3.0 ppm, signals of one methylene protons [a doublet of triplet between  1.30–1.40 (H-2) and a doublet 
of doublet between 1.50–1.60 (H-2')], four cis olefinic protons at  6.10–6.30 (dt, H-4), 5.50–5.80  
(dt, J = 9.7, 3.0 Hz, H-5), 5.30–5.70 (brd, J = 9.8 Hz, H-8), and 5.60–5.70 (dt, J = 10.2, 3.4 Hz, H-9). 
However, some signals are shifted when a double bond is present at C-5/C-6. In this case, a singlet of 
the olefinic proton H-5 is observed between  6.80–7.50 ppm. This proton resonates around 6.20 ppm 
when a ketone group is present at C-4. Endiandric acid derivatives with skeleton 2 exhibited, among 
other peaks, signals of methylene protons between  1.50–1.60 (H-6) and 1.80–1.90 (1H, H-6') and two 
cis olefinic protons between  6.10–6.30 (H-10) and 6.20–6.30 (H-11). Those of compounds with 
skeleton 1 or 2 bearing a methylenedioxyphenyl moiety exhibited in addition an ABX system of olefinic 
of three protons at  6.60–6.66 (1H, dd, J = 8.0, 1.6 Hz), 6.64–6.90 (1H, d, J = 1.6 Hz) and 6.72–7.20 
(1H, d, J = 8.0 Hz) [17,19,20,22–24,41,44,48,49,52]. Figure 1 summarises the range of 1H-NMR data 
of endiandric derivatives. 
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2  
Figure 1. Range of 1H-NMR chemical shift of tetracyclic endiandric acid (skeleton  
1 and 2) [9,13,18–20,31,32,41,48,49,52]. 
13C-NMR spectroscopy is very helpful in the structure elucidation of endiandric acid derivatives since 
chemical shift databases can be used to search for similar patterns. In addition, 13C-NMR chemical shifts 
tend to be more reproducible and are less influenced by solvent, temperature or pH [56,57]. The  
13C-NMR spectrum of tetracyclic endiandric acids exhibits among other signals 11 or 12 methines and 
one to two methylenes for the basic skeletons [21–24,33,34,44]. The signals of methines (C-1, C-3, C-7, 
C-10, C-11, C-12, C-13) and the methylene C-2 in derivatives with skeleton 1 and those of methines  
(C-1, C-2, C-3, C-4, C-5, C-7, C-8, C-9) and the methylene C-6 in compounds with skeleton 2 are 
characteristic for the tetracyclic endiandric acids [9,14,21,34,44]. The chemical shift of the carboxy 
group at C-6 in compounds with skeleton 1 helps to confirm the location of the double bond in cycle D. 
In fact, when the double bond is C5=C6, the carbon of the carboxyl group appears at around 170 ppm. In 
case of C4=C5 double bond, it appears at between 175 and 181 ppm [9,13,14,18–20,30,31,44,48,52]. 
However, some signals are shifted when the double bond is C5=C6. In this case, the olefinic carbon C-5 
appears at around 141 ppm in compound bearing a carboxylic group at C-6. This chemical carbon can 
shift to 145 ppm when hydroxyl is present at C-4 [9,13,18–20,31,32,48,52]. The chemical shift range (in 
ppm) of carbons of the tetracyclic endiandric skeletons are given in Figure 2. 
Figure 2. Range of 13C NMR chemical shift of the tetracyclic endiandric acid (skeleton 1 and 2). 
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2.2. Alkaloids and Amides 
Plants of Lauraceae are rich sources of bioactive alkaloids [58–65]. The majority of alkaloids isolated 
from Beilschmiedia species possess aporphine skeletons (71, Table 3) or benzylisoquinoline (72) skeletons. 
(+)-Predicentrine (73), which was first prepared by O-methylation of boldine (74), was isolated 
together with norpredicentrine (75) from the leaves of B. podagrica. Three aporphine alkaloids, 
isocorydine (76), glaucine (77), and (+)-N-methyllindcarpine (78) were obtained after subsequent 
investigation of the leaves of the same plant while laurelliptine (79) and isoboldine (80) were obtained 
from the bark [66,67]. Laurelliptine (79) was also obtained from the bark of B. elliptica together with 
the pale pink needles of isoboldine (80) [67,68]. Isoboldine (80) was identified as the major alkaloid 
from berries of B. tawa [46]. 
The phytochemical investigation of the leaves of B. alloiophylla has resulted in the isolation of the 
alkaloids 2-hydroxy-9-methoxyaporphine (81), laurotetanine (82), boldine (74), isoboldine (80), 
asimilobine (83) [29]. 
Table 3. Substitution pattern of aporphine alkaloids 73–86. 
 
Compounds R1 R2 R3 R4 R5 R6 Sources Ref. 
(+)-Predicentrine (73) OH OMe H OMe OMe Me B. podagrica [66] 
Boldine (74) OH OMe H OMe OH Me B. alloiophylla, B. kunstleri [29] 
Norpredicentrine (75) OH OMe H OMe OMe H B. podagrica [66] 
(+)-Isocorydine (76) OMe OMe OH OMe H Me B. podagrica [66] 
(+)-Glaucine (77) OMe OMe H OMe OMe Me B. podagrica [66] 
(+)-N-methylindcarpine (78) OH OMe OH OMe H Me B. podagrica [66] 
(+)-Laurelliptine (79) OMe OH H OMe OH H B. podagrica [67,68] 
(+)-Isoboldine (80) OMe OH H OMe OH Me B. alloiophylla, B. tawa [29,46] 
2-Hydroxy-9-methoxy aporphine (81) OH H H H OMe Me B. alloiophylla [29] 
(+)-Laurotetanine (82) OMe OMe H OMe OH H B. alloiophylla, B. kunstleri [29,31] 
()-Asimilobine (83) OH OMe H H H H B. alloiophylla [29] 
(+)-Norboldine (84) OH OMe H OMe OH H B. kunstleri [31] 
(+)-Cassithicine (85)  O-CH2- H OMe OH Me B. kunstleri [31] 
Nornuciferine (86) OMe OMe H H H H B. kunstleri [31] 
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Tetracyclic alkaloids with morphine skeleton (+)-oreobeiline (87) and (+)-6-epioreobeiline (88) together 
with other aporphine alkaloids secoboldine (89), liriodenine (90) and (S)-3-methoxynordomesticine (91) 
were also isolated by Mollataghi and colleagues from B. alloiophylla [29]. Two of these alkaloids, (+)-
oreobeiline (87) and (+)-6-epioreobeiline (88) were first isolated by Tillequin and colleagues from the 
wood of B. oreophila [47]. 
The benzylisoquinoline alkaloids O,O-dimethylannocherin A (92), (6,7-dimethoxy-4-methylisoquinolinyl)-
(4'-methoxyphenyl)methanone (93), (6,7-dimethoxy-1-isoquinolinyl)-(4'-methoxyphenyl)methanone 
(94), (±)-N-norarmepavine (95), (R)-()-armepavine (96), O,O-dimethylcoclaurine (97) and  
O-methylvelucryptine (98) were isolated from the leaves of B. brevipes [45]. One compound of this 
class, (+)-N-dimethylphyllocryptine (99), was obtained from B. alloiophylla [29]. 
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Dehatrine (100), an antimalarial bisbenzylisoquinoline alkaloid, was isolated in the frame of a 
bioguided investigation on antiplasmodial activity of the wood of the Indonesian medicinal plant B. 
madang [12]. 
 
The phytochemical investigation of the leaves of B. kunstleri afforded several alkaloids: (+)-N-
methylisococlaurine (101), (+)-cassythicine (85), (+)-laurotetanine (82), (+)-boldine (74), ()-pallidine 
(102), (+)-nornuciferine (86), noratherosperminine (103), (+)-N-dimethylphyllocaryptine (99), ()-
isocaryachine (104), and the amide ()-kunstleramide (105) [29,30]. Other amides, zanthonamide (106) and 
pipyahyine (107) have been isolated from the stem bark of B. zenkeri by Lenta and colleagues [18]. 
Additionally, a cyclostachine acid derivative obscurine (108) was isolated from the stem of B. obscura [28]. 
From the stem bark of B. erythrophloia three amides, N-trans-feryoltyramine (109), N-trans-feryoloctopamine 
(110) and beilschamide (111), were isolated [69]. 
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The chemical investigation of the bark of E. kingiana led to the isolation of a series of polyketides as 
a racemic mixtures, having each an amide function and named kingianins A–N (112–125). These amides 
possess an unusual pentacyclic carbon skeleton and was described for the first time in nature by Leverrier 
and coll. [42,43]. Seemingly, no alkaloids have been reported to date for the genus Endiandra. 
Biomolecules 2015, 5 923 
 
 
 
2.3. Lignans and Neolignans 
Plants of the Lauraceae family are sources of bioactive lignans [70–72]. The majority of lignans and 
neolignans isolated from the genus Beilschmiedia were obtained from the species B. tsangii.  
The investigation of the roots, leaves and stem of this species afforded the lignans ambo-(7R,8R,7'R,8'R)- 
3',4'-methylenedioxy-3,4,5,5'-tetramethoxy-7,7'-epoxylignan (126), ambo-(7R,8R,7'R,8'R)-3,4,3',4'-
dimethylenedioxy-5,5'-dimethoxy-7,7'-epoxylignan (127), beilschminol A (128), beilschminol B (129) 
together with other polymethylated derivatives 4,5-epoxybeilschmin A (130), 4,5-epoxybeilschmin 
B (131), beilschmin D (132), beilschmin A (133), beilschmin B (134), beilschmin C (135),  
ambo-(7S,8S,7'R,8'R)-3,3',4,4',5,5'-hexamethoxylignan (136), and three 1-phenylbutyl benzoates, 
tsangin A (137), B (138), and C (139) [22,23,25,26]. 
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The investigation of the dichloromethane extract of the leaves of B. kunstleri yielded an antioxidant 
neolignan, (+)-kunstlerone (140) [30]. 
Magnolol (141), an antibacterial neolignan, was isolated from different Endiandra species specifically 
E. xanthocarpa, B. volckii, E. bassaphila, E. leptodendron, E. monothyra and E. wolfii [40]. From the 
extracts of the leaves of E. xanthocarpa and E. palmerstonii, sesamin (142), a lignan known to be a 
phytoestrogen, was isolated [40]. 
From the roots of E. anthropophagorum the cyclobutane lignans, endiandrin A (143) and endiandrin 
B (144), together with ()-dihydroguaiaretic acid (145) and nectandrin B (146) were isolated. This type 
of lignan containing a cyclobutane moiety is rare in nature. Endiandrin A (143) and B (144) represent 
only the 23rd and 24th naturally occurring cyclobutane lignans [32,33]. 
 
2.4. Flavonoids and Chalcones 
Flavonoids have been isolated from many species of Lauraceae family [73]. However, this class of 
secondary metabolites has not been reported to date in Endiandra. They were obtained only from two 
species of Beilschmiedia: B. miersii and B. zenkeri. The rare quercetin-5-methyl ether known as azaleatin 
(147) was isolated from the leaves of B. miersii together with quercetin (148), quercetrin (149), 
isoquercetrin (150), afzeloside (151) and mikwelianin (152) [21]. 
 
Five methoxylated flavonoid derivatives, (2S,4R)-5,6,7-trimethoxyflavan-4-ol (153), (2S,4R)-4,5,6,7-
tetramethoxyflavan (154), beilschmieflavonoid A (155), beilschmieflavonoid B (156), and 5-hydroxy-7,8-
dimethoxyflavanone (157), were isolated from the stem bark of B. zenkeri [18]. Beilschmieflavonoids A 
(155) and B (156) possess an unusual C4-O-C4'' linkage that has been found only in a biflavonoid isolated 
from Tephrosia tepicana (Leguminosae) [74]. Only two chalcones, 2',6'-dihydroxy-4-isoprenyloxy- 
3,4-(3''',3'''-dimethylpyrano)chalcone (158) and 4,2',6'-trihydroxy-3',4'-methylenedioxy-3-isopent-2-
enylchalcone (159), were reported from the genus Beilschmiedia and precisely from the Brazilian species 
Beilschmiedia tovarensis [13]. No chalcone has been reported from the genus Endiandra. 
Biomolecules 2015, 5 925 
 
 
 
2.5. Benzene Derivatives 
Benzene compounds have been isolated mostly from plants of the Beilschmiedia genus. Some of  
these compounds are benzaldehyde derivatives such as vanillin (160), p-hydroxybenzaldehyde (161), 
3,4,5-trimethoxybenzaldehyde (162), isolated from the root and stem of B. tsangii [22,23,25]. Vanillin 
(160) was also isolated from the stem bark of B. erythrophloia [69]. Sarisan (163), an insect repelling allyl 
benzenoid, was isolated from the leaves of B. miersii [27,50]. The benzopyran oligandrol (164), was isolated 
from the bark of B. oligandra [40]. Its methylated derivative, oligandrol methyl ether (165), was obtained 
from the root of B. erythrophloia together with the benzenoids farnesylol (166) and -tocopheryl quinone 
(167) [41,49]. Compound 167 was also isolated from the stem of B. tsangii and B. erythrophloia [25,69]. 
Another benzopyran derivative, -tocopherol (168), was isolated from the roots of B. tsangii. 
 
2.6. Terpenoids 
Sesquiterpenes and triterpenoids are two classes of terpenoids mostly isolated from plants of 
Beilschmiedia and Endiandra genera. 
The triterpenoids ursolic acid (169) and squalene (170) were isolated from the roots and leaves of  
B. tsangii, respectively [22,26]; lupeol (171) and 3-O-acetyl betulinic acid (172) were obtained from the 
roots of B. erythrophloia; betulinic acid (173) from the stem bark of B. zenkeri [18] and -amyrone (174) 
from B. alloiophylla [29]. 
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The skeletons of sesquiterpenes isolated from both genera are different. They are either bi-, tri-, or 
polycyclic with different degrees of oxidation. From the roots of B. tsangii, (+)-5-hydroxybarbatenal (175), 
(4R,5R)-4,5-dihydroxycaryophyll-8(13)-ene (176), octahydro-4-hydroxy-3-methyl-7-methylene--(1-
methylethyl)-1H-Indene-1-methanol (177), eudesm-4(15)-ene-1,6-diol (178), were isolated [22]. 
From its stem, 2,6,11-trimethyldodeca-2,6,10-triene (179) was obtained [25]. Suberosol B (180) was 
obtained from the roots of B. erythrophloia and (+)--curcumene (181) from the leaves of  
E. xanthocarpa [40]. The investigation of the leaves of another Endiandra species, E. baillonii  
also provided the sesquiterpenes ishwarane (182), -copaene (183), cis/trans-calamanene (184), and  
(+)--curcumene (181) [40]. 
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Sesquiterpenes and monoterpenes have been identified as the major constituents of the essential oils 
obtained from species of the genus Beilschmiedia (Table 4). 
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Table 4. Chemical composition of essential oils of Beilschmiedia species. 
Species Major Constituents 
B. miersii 
Leaf oil: Germacrene D (185, 24.8%), -terpinene (186, 10%), -curcumene (187, 9.6%),  
1-octen-3-yl acetate (188, 8.2%), (E)--ocimene (189, 6.4%) [51] 
B. tarairie Leaf oil: -terpinene (186, 17.8%), -pinene (190, 9.4%), germacrene D (185) [75] 
B. brenesii 
Leaf oil: germacrene D (185, 19.3, (E)-caryophyllene (191, 13.4%), 2-undecanone (192, 12.8%), 
-copaene (183, 9.0), trans-2-hexanal (193,8.8%) [76] 
B. costaricensis Leaf oil: -bisabolol (194, 72.1%), Cis 2-hexenol (195, 5.2%), -terpinene (186, 3.0%) [76] 
B. alloiophylla 
Leaf oil: germacrene D (185, (18.9), cis--ocimene (196, 18.8%), -pinene (190, 3.0%),  
trans--ocimene (189, 9.3%), bicyclogermacrene (197, 9.1%) [77] 
B. talaranensis Leaf oil: germacrene D (185, 54.9%), -caryophyllene (191, 14.8%), -terpinene (186, 3.6%) [77] 
B. madang 
leaf oil: -cadinene (198, 17.0%), -caryophyllene (191, 10.3%), -cubebene (199, 11.3%), and 
-cadinol (200, 5.8%) [78];  
bark oil: -cadinene (195, 20.5%), -caryophyllene (191, 6.7%), -cubebene (199, 15.6%), and  
-cadinol (200, 10.6%) [78] 
B."chancho 
chancho" 
Leaf oil: -caryophyllene (191, 16.6%), bicyclogermacrene (197, 14.1%), -pinene (190, 7.7%), 
germacrene D (185, 6.6%), -cadinene (198, 6.1%) [79] 
B.pendula 
leaf oil: -pinene (190, 10.4%), -caryophyllene (191, 8.6%), c (201, 7.9%) and 
bicyclogermacrene (197, 7.2%) [80]; branch oil: -caryophyllene (191, 17.3%), -selinene (202, 
9.1%), bicyclogermacrene (197, 8.9%), -cadinol (200, 5.8%) and spathulenol (203, 4.6%) [80] 
B. erythrophloia 
Leaf oil: -caryophyllene (191, 22.6%), -humulene (204, 21.9%), terpinen-4-ol (205, 5.3%),  
cis--ocimene (196, 5.1%), sabinene (206, 5.0%), limonene (207, 4.5%) [81] 
 
2.7. Cyanoglycosides 
Chemotaxonomic studies indicated that terpenoids and alkaloids are common among plants of the 
Lauraceae family. In contrast, organic cyanides are very rare in Lauraceae and have only been reported 
from few species such as Cinnamomum camphora, Litsea glutinosa and Nectandra megaptamica.  
The investigation of 39 Australian Lauraceae species indicated that only B. collina was cyanogenic.  
Biomolecules 2015, 5 928 
 
 
In fact, from the methanol extract of B. collina, the first cyanogenic compound taxiphillin (208) was 
isolated from this genus [82]. 
 
2.8. Other Metabolites 
Steroids were isolated from extracts of many species from Beilschmiedia. Stigma-5-en-3-one (209),  
-tocospiro B (210), 3-hydroxystigma-5-en-7-one (211), stigmast-4-ene-3,6-dione (212), ergone (213),  
-sitostenone (214), 6-hydroxystigma-4-en-3-one (215) were isolated from the root of B. tsangii [25,26].  
-Sitosterol (216) was isolated from the stem of B. tsangii together with the pyrone derivatives  
-tocospiro B (217) [25]. 6-Hydroxystigma-4-en-3-one (210) and 3-hydroxystigma-5-en-7-one (211) 
were also obtained from B. erythrophloia [41]. The fatty acid esters 2,3-dihydroxypropyl heptacosanoate (218), 
1-(26-ferulyloxy hexacosanoyl)-glycerol (219) and 1-(26 hydroxyhexacosanoyl)-glycerol (220) were 
isolated from the stem of B. obscura together with 3-acetylsitosterol (221) and -sitosterol-3-O-D-
glucopyranoside (222) [18]. -Sitosterol (216) and -sitosterol-3-O-D-glucopyranoside (222) were also 
isolated from B. zenkeri [18]. 
 
3. Biological Activities 
Several interesting biological activities for the Beilschmiedia and Endiandra constituents have been 
reported, including antibacterial, anticancer, antifungal, antiinflammatory, antileishmanial, antiplasmodial 
and cytotoxic properties as well as -glucosidase inhibiting activity. 
3.1. Anticancer and Cytotoxic Activities 
Cancer cells that avoid apoptosis continue to proliferate uncontrollably. Apoptosis is an ordered and 
orchestrated cellular process that occurs in physiological and pathological conditions. An understanding 
of the underlying mechanism of apoptosis is important as it plays a pivotal role in the pathogenesis of 
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many diseases. Degenerative diseases are characterized by too much apoptosis, while in the case of 
cancer, too little apoptosis occurs. Thus, resisting apoptosis is a key process in cancer development and 
progression [83]. Targeting the antiapoptotic proteins such as those of the Bcl-2 family members  
(Bcl-2, Bcl-xL, Bcl-w, Mcl-1, and A1) is essential for cancer treatment or preventive drug discovery.  
In addition, it has been shown that most cancers depend on more than one antiapoptotic Bcl-2 member 
for survival. The discovery of new selective inhibitors of antiapoptotic proteins is thus important for the 
search for anticancer drugs [84–87]. 
Endiandric acids derivatives isolated from Beilschmiedia and Endiandra species were screened for 
Bcl-xL and Mcl-1 binding affinities (Table 5). Amongst the tested compounds, ferrugineic acid B (38) 
exhibited the best binding affinity for Mcl-1 (85% inhibition at 100 	M) while ferrugineic acid C (39) 
showed the highest binding affinity to Bcl-xL (93% inhibition at 100 	M). Two compounds, ferrugineic 
acids B (38) and C (39), exhibited significant binding affinities for both antiapoptotic proteins. Apart 
from tsangibeilin B (29) and ferrugineic acid J (46), the compounds that exhibited good binding affinity 
to Mcl-1 possess a C13 fused tetracyclic ring system with 4,5 and 8,9 double bonds. In the group of 
compounds with an C11 fused tetracylic ring system, only kingianic acid C (61) showed significant 
binding affinity to Mcl-1. No binding was detected from the compounds of this last fused tetracylic ring 
system for Bcl-xL. After the correlation between the structures and activities of compounds with C13 
fused tetracyclic ring system, Appel and collaborators postulated that the length of the saturated carbon 
side chain, the -oriented C-4 hydroxy group and the terminal 4-hydroxyphenyl ring, play a crucial role 
for Bcl-xL and Mcl-1 binding affinities [24,34]. 
Table 5. Binding affinities of some endiandric acid derivatives to antiapoptotic proteins Bcl-xL 
and Mcl-1. 
Compound 
Bcl-xL/Bak Binding Affinity Mcl-1/Bid Binding Affinity 
% at 100 	M Ki 	M % at 100 	M Ki 	M 
Tsangibeilin B (29) 26 ± 2.5 ND 81 ± 2.4 ND 
Ferrugineic acid A (37) 22 ± 2 >100 0 14 ± 33 
Ferrugineic acid B (38) 60 ± 6 19.2 ± 1.6 85 ±2 12.0 ±5.0 
Ferrugineic acid C (39) 93 ± 3 12 ± 0.2 82 ± 2 13.0 ± 5.0 
Ferrugineic acid D (40) 39 ± 3 >100 82 ± 2 5.2 ± 0.2 
Ferrugineic acid E (41) 20 ± 1 ND 14.3 ± 3 ND 
Ferrugineic acid F (42) 7 ± 1 ND 0 ND 
Ferrugineic acid G (43) 17 ± 1 ND 3 ± 1 ND 
Ferrugineic acid I (45) 35 ± 1 ND 7 ± 2 ND 
Ferrugineic acid J (46) 58 ± 7 19.4 ± 3 81 ± 3 5.9 ± 0.5 
Kingianic acid F (47) 22 ± 2.9 ND 80 ± 0.7 ND 
Kingianic acid G (48) 19 ± 1.6 ND 47 ± 2.9 ND 
Kingianic acid A (54) 21 ± 1.8 ND 36 ± 2.3 ND 
Endiandric acid M (56) 10 ± 0.5 ND 39 ± 2.9 ND 
Kingianic acid C (61) 25 ±1.7 ND 75 ± 1.1 ND 
Kingianic acid E (63) 1 ± 0.8 ND 8 ± 5.5 ND 
U-Bak (Ki)  0.0012 ± 103  ND 
U-Bid (Ki)    0.016 ± 0.002 
ABT-737 (Ki) 57 ± 10 nM  47 ± 22 nM  
NT: Not tested; U-Bak and U-bid correspond to unlabeled peptides Bak and Bid, respectively. 
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The binding affinity of the racemic mixtures of kingianin A–N (112–125) isolated from E. kingiana 
was evaluated on Bcl-xL by competition against the fluorescently tagged BH3 domain of the protein 
Bak. Racemic mixtures of kingianins G–L (118–123) exhibited good binding affinity with kingianin G 
(118) exhibiting the best potency with a Ki value of 2 ± 0 	M (Table 6). The pure enantiomers of these 
active racemates obtained using chiral preparative HPLC were evaluated for their binding affinity. 
Taking into account the stereochemistry of the compounds, the binding affinity was significantly higher 
for the ()-enantiomers compared to the (+)-enantiomers, as illustrated by the comparison of the Ki for 
() and (+)-kingianin derivatives (Table 6) [43]. 
Table 6. Bcl-xL binding affinity of compounds 112–125 (Ki in 	M). 
Compound 
Bcl-xL Ki 
Racemic mixture () Enantiomer (+) Enantiomer 
Kingianin A (112) 213 ± 83 60 ± 1.5 >300 
Kingianin B (113) >300   
Kingianin C (114) >300   
Kingianin D (115) >300   
Kingianin E (116) >300   
Kingianin F (117) 231 ± 47   
Kingianin G (118) 2 ± 0 1.0 ± 0.2 5.0 ± 1.0 
Kingianin H (119) 18 ± 7 4.0 ± 0.4 27.0 ± 0.6 
Kingianin I (120) 18 ± 3 12.0 ± 1.1 16.0 ± 2.2 
Kingianin J (121) 29 ± 6 9.0 ± 0.2 25.0 ± 3.2 
Kingianin K (122) 80 ± 36 6.0 ± 0.2 112 ± 45 
Kingianin L (123) 36 ± 11 4.0 ± 0.1 71.0 ± 10 
Kingianin M (124) 236 ± 34   
Kingianin N (125) 177 ± 9   
Unlabeled Bak (BH3) 0.90 ± 0.27   
Endiandric acid analogues isolated from unidentified Gabonese Beilschmiedia species were screened 
for their cytotoxicity against NCI-H460 (human lung cancer cell lines); PC-3 (prostate adenocarcinoma 
cell lines), and M14 (amelanotic melanoma cell lines) using an MTT assay. All the isolated compounds 
were inactive against PC-3, and M14 cell lines. Beilschmiedic acids K (17), L (19), M (18), N (20) and 
A (8) exhibited moderate cytotoxicity against NCI-H460 human lung cancer cells with IC50 values of 5.5; 
5.9; 4.4; 8.7; 19; 6.1 	M, respectively. This was the first report of the cytotoxicity of this class of secondary 
metabolites [48]. Subsequently, other endiandric acid derivatives kingianic acids A (59), C (61), E (63),  
F (47), G (48), endiandric acid M (56), and tsangibeilin B (29) isolated from E. kingiana were evaluated for 
their cytotoxicity activity against A549 (lung adenocarcinoma epithelial cell lines), HT29 (colorectal 
adenocarcinoma cell lines) and PC3 cell lines. As reported by Williams et al. [48], all compounds were 
inactive against prostate adenocarcinoma cancer cell lines. Kingianic acid A (59) showed weak activity against 
HT-29 and A549 cell lines with IC50 values of 35 ± 0.2 	M and 85.4 ± 0.2 	M, respectively. Kingianic acid 
E (63) showed moderate cytotoxic activity against A549 and HT-29 cell lines with IC50 values of  
15.36 ± 0.19 	M and 17.10 ± 0.11 	M, respectively [34]. The other tested compounds showed very weak 
or were devoid of cytotoxic activity against the cell lines tested. 
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Ferrugineic acids A–J (37–46) and K (58), isolated from B. ferruginea, were screened for cytotoxicity 
against HCT-116 (Human colorectal carcinoma) and K562 (human leukemia) cancer cell lines. All these 
compounds were devoid of cytotoxicity on the two cancer cell lines tested at concentrations up to 50 μM [24]. 
The cytotoxicity activities of lignans and other constituents of the stem of B. tsangii were evaluated 
in vitro against P-388 and HT-29 cell lines. Beilschmin A (133), B (134), C (135), tsangin A (137), B 
(138), 2,6,11-trimethyldodeca-2,6,10-triene (179), -tocopheryl quinone (167) and -tocospiro B (217) 
were cytotoxic (IC50 below 4 μg/mL) against the P-388 cell lines. Tsangin A (137), B (138) and  
-tocospiro B (217) were the most cytotoxic with IC50 values of 0.81 ± 0.009, 0.42 ± 0.03, and 0.83 ± 
0.09 μg/mL, respectively, against the P-388 cell lines while 2,6,11-trimethyldodeca-2,6,10-triene (179) 
and -tocospiro B (217) exhibited the best potency against the HT-29 cell line amongst the isolated with 
IC50 values of 2.2 ± 0.3 and 1.5 ± 0.2 μg/mL, respectively [25]. 
Endiandrin A (143), endiandrin B (144), ()-dihydroguaiaretic acid (145) isolated from  
E. anthropophagorum and the synthesized derivative cinbalansan (223) were also evaluated for their 
cytotoxicity against A549 cell line. In high-content screening (HCS) assays, ()-dihydroguaiaretic acid 
(145) was found to be the most potent compound, displaying cytotoxicity against the A549 cell line with 
an IC50 of 7.49 	M after 24 h incubation in both propidium iodide and Yo-PRO-1 assays. It effect was 
less pronounced in the mitotracker assay with IC50 of 31.2 	M. Endiandrin A (143), and B (144) were 
found to have moderate effects with an inhibition of 76% and 75% at 100 	M, respectively. Cinbalansan 
(223) was found to have much less effect with a maximum inhibition of 34% [32]. 
 
Alkaloids isolated from the leaves of B. brevipes exhibited cytotoxicity activity against P-388  
murine leukemia cell lines. (6,7)-Dimethoxy-1-isoquinolinyl)-(4'-methoxyphenyl)methanone (94),  
O,O-dimethylcoclaurine (98), O-methylvelucryptine (97), (R)-()-armepavine (96) and (±)-N-norarmepavine 
(95) were active with IC50 values of 18.7, 6.5, 17.3, 42.2 and 44.5, respectively [45]. 
The stem bark and leaf extracts of B. acuta were evaluated against a panel of human cancer cell lines, 
including various multidrug-resistant phenotypes. The leaf extracts showed IC50 values below or around 
30 mg/mL in 10 cell lines. Interestingly, among them were multidrug-resistant cell lines, e.g., P-glycoprotein 
overexpressing CEM/ADR5000, breast cancer resistance protein-transfected MDA-MB-231-BCRP, 
TP53 knockout cells (HCT116 p53/), and mutation-activated epidermal growth factor receptor-transfected 
U87MG.EGFR cells [88]. 
()-Kunstleramide (105) a dienamide from B. kunstleri displayed cytotoxic effect in MTT assays 
against A375 (melanoma cell lines), A549, HT-29, PC-3 and WRL-68 (normal liver) cell lines with  
EC50 values of 64.65, 44.74, 55.94, 73.87 and 70.95 	g/mL, respectively [31]. Other amides  
N-trans-feryoloctopamine (110) and beilschamide (111) isolated from the stem of B. erythrophloia 
exhibited cytotoxic effects in vitro. They were active against CCRF-CEM (human lymphoblastic 
leukemia) cell line with IC50 values of 10.3 and 21.2 	g/mL, respectively [69]. 
Biomolecules 2015, 5 932 
 
 
The essential oil obtained from the leaf of B. erythrophloia exhibited cytotoxic activity against human 
OEC-M1 (oral squamous cancer), J5 (hepatocellular carcinoma), A549, HT-29, UACC-62 (melanoma) 
and K562 (leukemic) cell lines. The results showed that treatment with the essential oil for 48 h reduced 
the viability of OEC-M1 cells, J5 cells, A549 cells, HT-29 cells, UACC-62 cells, and K562 cells, with 
IC50 around 32.6, 48.6, 38.8, 18.9, 5.8, and 6.8 	g/mL, respectively [77]. 
3.2. Antimalaria Activity 
Malaria remains one of the most notorious infectious diseases in the world. It constitutes a public 
health problem in more than 90 countries, inhabited by about 40% of the world’s population. The World 
Health Organisation estimates that there are 300–500 million malaria cases annually, causing 2–3 million 
deaths, mostly among children under five years old. In the last decades, resistance of Plasmodium 
falciparum, the causative agent of the most severe form of the disease, to several antimalarials, especially 
chloroquine and antifolates, became widely disseminated, while the cost of effective treatment is 
prohibitive for the large majority of the population in developing countries. For these reasons, new 
effective and affordable antimalarials are urgently needed [89–91]. In this perspective, extracts and some 
compounds isolated from Beilschmiedia species were screened for their antiplasmodial potency. 
Cryptobeilic acids A–D (33–36) and tsangibeilin B (29) isolated from B. cryptocaryoides collected 
in Madagascar exhibited antiplasmodial activity in vitro against the chloroquine-sensitive strain of  
P. falciparum NF54 with IC50 values of 17.7, 5.35, 14.0, 10.8 and 8.2 μM, respectively. However, the 
cytotoxicity of these compounds against the L6 cell lines indicated low selectivity [52]. 
The antiplasmodial bioassay guided separation of the chemical constituents of the wood of the 
Indonesian medicinal plant B. madang led to the isolation of the bisbenzylisoquinoline dehatrine (100), 
that exhibited potent antiplasmodial activity against the chloroquine-resistant strain P. falciparum k1 
with IC50 value of 0.17 	M, and which is comparable to that of the reference drug quinine against the 
same strain in vitro [12]. 
Pipyahyine (107), 5-hydroxy-7,8-dimethoxyflavanone (157), and betulinic acid (174) isolated from 
B. zenkeri exhibited antiplasmodial activity against the chloroquine-resistant strain of P. falciparum W2 
with IC50 values of 3.7, 9.3 and 5.2 	M, respectively. Their activity were moderate compare to 
chloroquine (IC50 value of 0.13 	M), which was used as the positive control [18]. 
Lupeol (171), which showed in vitro inhibitory activity against the P. falciparum 3D7 strain with an 
IC50 value of 27.7 ± 0.5 	M, was shown to cause a transformation of the human erythrocyte shape toward 
that of stomatocytes [92]. 
3.3. Anti-Asthmatic and Other Anti-Inflammatory Activities 
Asthma is a disease of the immune system, which is expressed for example as bronchial asthma in 
the form of acutely occurring, paroxysmal dyspnea with expiratory ventilation disability. Studies 
reported that persistent inflammation is central to the pathogenesis of asthma. So far, asthma therapy 
uses drugs which alleviate the symptoms but do not inhibit the mechanism responsible for the expression 
of inflammatory mediators such as the cytokines interleukin-4 (IL-4), interleukin-13 (IL-13) and 
interleukin-5 (IL-5) [93,94]. Endiandric acid H (7), obtained from the plant Beilschmiedia fulva, and its 
synthetic derivatives, known as c-maf, and NFAT inhibitors are used for producing a medicament,  
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in particular for the treatment of allergic disorders, asthmatic disorders, inflammatory concomitant 
symptoms of asthma and/or of diseases which can be treated by inhibiting c-maf and NFAT [53,54]. 
The anti-inflammatory activities of extracts of B. tsangii have been studied. The methanol extract of 
the roots of B. tsangii showed potent inhibition of nitrogen monoxide (NO) production. Amongst the 
compounds isolated from this extract by bioassay guided separation, endiandric acid analogues 
endiandramide A (32) and B (57) with N-isobutylamide group exhibited potent iNOS inhibitory 
activities with IC50 values of 9.59 and 16.40 	M, respectively. Other isolates, tsangibeilin A (26), 
tsangibeilin B (29), endiandric acid K (54), endiandric acid M (56), endiandric acid L (55), and the 
lignans beilschminol A (128), beilschminol B (129), tsangin C (139) and tsangibeilin D (31), exhibited 
moderate anti-inflammatory activity with IC50 values in the range of 30–96 μM [22,23]. 
Synthetic glucocorticoids are widely used as drugs to treat inflammatory conditions such as 
rheumatoid arthritis or dermatitis and as adjunctive therapy for conditions such as autoimmune diseases. 
However, current glucocorticoid drugs act non-selectively, with the potential of long-term impairment 
of many physiological anabolic processes. Therefore, research aiming at the discovery of selective novel 
glucocorticoid receptor (GR) binders may provide new and improved drug therapies [95–98].  
The bioguided fractionation of the dichloromethane extract of Endiandra anthropophagorum based on 
GR binding assay resulted in the isolation of the active lignans endiandin A (143), nectantin B (146) and 
()-dihydroguaiaretic acid (145) which displayed IC50 values of 0.9, 27 and 35 	M, respectively. The 
di-acetylated (224) and di-methylated (225) derivatives of endiandrin A also exhibited good activities 
with IC50 of 34 and 13 μM, respectively. From the structure–activity correlation, David and collaborators 
suggested that the constrained four-membered which has implications in the spatial arrangements of the 
substituents is important for the potent GR activity. In addition, increasing the steric bulk of the C-4/C-4' 
substituents in the cyclobutane series was shown to significantly reduce the activity [33]. 
 
3.4. Antimicrobial Activity 
Antibacterial activity of extracts and a number of endiandric acid derivatives and other constituents 
isolated from Beilschmiedia and Endiandra species have been studied. 
Beilschmiedic acid A (8), B (9), and C (10), isolated from the stem bark of B. anacardioides, exhibited 
antibacterial activities against a wide range of microorganisms (Bacillus subtillis, Micrococcus luteus, 
Streptococcus faecalis) with minimum inhibitory concentrations (MICs) of 0.7–364 	M. Compound 10 was 
found to be the most active derivative against the three tested strains with MICs of 5.6, 0.7 and 22.7 	M, 
respectively. Compounds 9 (MIC value of 11.3 	M) and 10 (MIC value of 5.6 	M) were found to be 
more active than the reference drug ampicillin (MIC value of 89.5 μM) against B. subtillis. Compound 10 
was also more active than the reference drug ampicillin (MIC value of 5.58 μM) against M. luteus [17]. 
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Compound 8 and other endiandric acid derivatives beilschmiedic acids I–O (15–21), isolated from an 
unidentified Gabonese Beilschmiedia species, exhibited potent antibacterial activity against a clinical 
isolate of methicillin-resistant S. aureus (MRSA) with MIC values between 10 and 13 	g/mL [48]. 
Cryptobeilic acids A (33) and B (34) isolated from B. cryptocaryoides displayed antibacterial activity 
against Escherichia coli 6r3 with MIC values of 10 and 20 	g/mL, respectively. Their activity were 
moderate compared to that of the reference drug ampicillin (MIC value of 5 	g/mL) [52]. 
Endiandric acid erythrophloin C (24) with phenyl in the side chain isolated from B. erythrophloia 
exhibited antitubercular activity against Mycobacterium tuberculosis with MIC of 50 	g/mL [41]. 
In addition to endiandric acid derivatives, other constituents of Beilschmiedia and Endiandra genera 
have also exhibited antibacterial activity in vitro against some strains of bacteria. The amide pipyahyine 
(107) and beilschmieflavonoid B (156) isolated from the stem of B. zenkeri exhibited antibacterial activity 
in vitro against Bacillus subtilis, P. agarici and S. minor with MICs between 81.5–197.5 	M [18]. 
Magnolol (141), a neolignan isolated from different Endiandra species, showed strong antibacterial 
activities against both Propionibacterium acnes and Propionibacterium granulosum, which are  
acne-causing bacteria with the MIC value of 9 	g/mL [99]. 
Beilschmin A (133) and B (134), two lignans isolated from B. tsangii, exhibited potent antitubercular 
activities with MICs of 2.5 and 7.5 	g/mL, respectively. These compounds were more active than  
their corresponding epoxy-analogues, 4,5-epoxybeilschmin A (130) (IC50 of 30 μg/mL) and  
4,5-epoxybeilschmin B (131 (IC50 of 40 	g/mL). As reported by Chen et al. [48], the epoxidation of 
the C4/C5 bond of compounds 133 and 134 considerably reduce their antibacterial activity against  
M. tuberculosis. Beilschmin A (133) with MICs of 2.5 	g/mL was most active than the reference 
compound, ethambutol (MIC of 6.2 μg/mL) [26]. The sesquiterpene suberosol B (180) isolated from  
B. erythrophloia also exhibited potent antitubercular activity against M. tuberculosis H37Rv in vitro 
with MIC of 28.9 μg/mL [41]. 
The methanol extract of the wood of B. tovarensis showed significant antibacterial activity results 
against Staphylococcus aureus and Enterococcus faecalis [13]. The methanol extract of the fruits of  
B. obscura showed antibacterial activity against multi-resistant drugs strains of Escherichia coli, 
Enterobacter aerogenes, Klebsiella pneumoniae, Enterobacter cloacae, Pseudomonas aeruginosa, and 
Providencia stuartii with MICs between 16–128 	g/mL [100]. 
Essential oils from the leaves and bark of B. madang showed moderate antibacterial activity towards 
B. subtilis and S. aureus with identical minimum inhibitory concentrations (MIC), 125 	g/mL. They also 
exhibited activity towards E. faecalis with MIC value of 250 	g/mL. Both oils were also found to be 
active against Gram-negative bacteria, K. pneumoniae with MIC value of 250 	g/mL [77]. 
The antifungal activities of extracts and the isolates from Beilschmiedia and Endiandra were also 
reported. The essential oils from the bark of B. madang showed strong antifungal activity towards 
Aspergillus niger and A. fumigatus with identical MIC values, 62.5 	g/mL [78]. 
The crude methanolic extract of B. alloiophylla was found to be active against Candida albicans  
in vitro. Alkaloids isolated from this extract boldine (74), 2-hydroxy-9-methoxyaporphine (81), laurotetanine 
(82), secoboldine (89), isoboldine (80), asimilobine (83), oreobeiline (87), 6-epioreobeiline (88), 
liriodenine (90), (S)-3-methoxynordomesticine (91) and the triterpenoid -amyrone (174) exhibited good 
antifungal activity against the same strain with MICs in the range of 8–64 	g/mL [29]. Paulo and 
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collaborators reported moderate antifungal activity for laurelliptine (79) and isoboldine (80) in vitro 
against Tricophyton rubrum and Microsporum gypseun [101]. 
3.5. Other Activities 
Essential oil from the leaves of Beilschmiedia madang exhibited cholinesterase and tyrosinase 
inhibiting activities in vitro with inhibition of 55.2%, 60.4%, and 53.1% for acetyl-, butyrylcholinesterase 
and tyrosinase at 1000 	g/mL, respectively [78]. The crude methanolic extract of B. alloiophylla 
inhibited acetylcholinesterase and -glucosidase in vitro. Four compounds from this extract, oreobeiline (87), 
6-epioreobeiline (88), -amyrone (174), and (S)-3-methoxynordomesticine (91), displayed moderate 
inhibitory activity against -glucosidase with IC50 values of 8.0, 10.0, 20.0, and 10.0 	M, respectively. 
Other isolates from the same extract, 2-hydroxy-9-methoxyaporphine (81), laurotetanine (82) and 
liriodenine (90), displayed strong inhibitory activity against AchE with IC50 values of 2.0, 3.2 and  
3.5 	M, comparable to that of the reference substance huperzine (IC50 values of 1.8 	M) [29]. 
The essential oils from the leaves of B. tilaranensis and B. brenesii exhibited enzyme inhibitory 
activities against cruzain, a potential therapeutic target for Chagas’ disease, a parasitic disease caused 
by Trypanosoma cruzi and that occurs mostly in South and Central American countries, with IC50 values 
of 23.6 	g/mL and 61.9 	g/mL, respectively [102–104]. 
The crude methanolic extract of B. alloiophylla was shown to exhibit antileishmanial activity in vitro. 
Compounds isolated from this extract, 2-hydroxy-9-methoxyaporphine (81), laurotetanine (82), 
liriodenine (91), boldine (74), secoboldine (90), isoboldine (80), asimilobine (83), oreobeiline (87),  
6-epioreobeiline (88), -amyrone (174), and (S)-3-methoxynordomesticine (91) exhibited moderate 
activity with IC50 values in the range of 10–50 	M [29]. 
The essential oils from B. madang exhibited weak DPPH radical scavenging activity (IC50 leaf 
oil, 263.9 	g/mL; bark oil, 212.0 	g/mL) compared to standard antioxidant, butylated hydroxytoluene 
(IC50 of 18.5 	g/mL) [78]. ()-Kunstleramide (105) an dienamide from B. kunstleri exhibited very  
poor dose-dependent inhibition of DPPH (2,2-diphenyl-1-picrylhydrazyl) activity, with an IC50 value  
of 179.5 ± 4.4 	g/mL [31]. 
4. Conclusions 
The genera Beilschmiedia and Endiandra include ca. 250 and ca. 125 species, respectively.  
Only 31 species of Beilschmiedia and 11 species of Endiandra have been investigated phytochemically, 
indicating that there are still many species that have received little or no attention. Secondary metabolites 
isolated from the two genera, can be classified as endiandric acid derivatives (30.9%), alkaloids and 
amides (23.7%), lignans and neolignans (9.5%), flavonoids and chalcones (5.8%) and others (30.21%: 
terpenoids, benzene derivatives, steroids, cyanoglycoside, fatty acids). Although being the majority of 
the isolates, the endiandric acid derivatives were not isolated from all species of Beilschmiedia or 
Endiandra investigated. This class of compounds and alkaloids is more widespread and the investigation 
of the remaining species could led to new derivatives. Bioassay on extracts and secondary metabolites 
of these species revealed pronounced biological properties, such as Bcl-xL and Mcl-1 binding affinity, 
-glucosidase inhibiting activity, antimicrobial, anti-inflammatory, antiplasmodial, and cytotoxic 
properties. In addition to these bioactive secondary metabolites, essential oils from these species displayed 
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good biological activities against a wide range of microorganisms and also enzyme inhibitory properties. 
The structural diversity of Beilschmiedia and Endiandra constituents and their interesting biological 
activities indicate that they are two potential sources of other new drugs such as that used in the treatment 
of asthma. 
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